{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:01:39Z","timestamp":1789621299379,"version":"build-2803163510"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T00:00:00Z","timestamp":1479254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0164692","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T13:27:06Z","timestamp":1479302826000},"page":"e0164692","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation"],"prefix":"10.1371","volume":"11","author":[{"given":"Alexander","family":"Flood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"McAdams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,11,16]]},"reference":[{"key":"ref1","article-title":"National Strategy for Pandemic Influenza: Implementation Plan","year":"2006"},{"key":"ref2","first-page":"25","article-title":"US Policy Regarding Pandemic-Influenza Vaccines","year":"2008"},{"key":"ref3","article-title":"Pandemic Influenza Preparedness Spending","year":"2009"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist<sup>\u00ae<\/sup>; Fluenz<sup>\u2122<\/sup>): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"NJ Carter","year":"2011","journal-title":"Drug"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.vaccine.2005.07.081","article-title":"Stability of influenza sub-unit vaccine. Does a couple of days outside the refrigerator matter?","volume":"24","author":"F Coenen","year":"2006","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejps.2004.05.007","article-title":"Physicochemical studies on the stability of influenza haemagglutinin in vaccine bulk materials","volume":"23","author":"DM Luykx","year":"2004","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.vaccine.2004.06.049","article-title":"A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats","volume":"23","author":"J Huang","year":"2004","journal-title":"Vaccine"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s11095-008-9559-6","article-title":"Development of stable influenza vaccine powder formulations: challenges and possibilities","volume":"25","author":"JP Amorij","year":"2008","journal-title":"Pharmaceut Res"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"D Chen","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"1\u20132","key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00423-3","article-title":"Lyophilization and development of solid protein pharmaceuticals","volume":"203","author":"W Wang","year":"2000","journal-title":"Int J Pharm"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijpharm.2015.01.053","article-title":"Stability of collapse lyophilized influenza vaccine formulations","volume":"483","author":"C Anamur","year":"2015","journal-title":"Int J Pharm"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.addr.2011.07.006","article-title":"Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development","volume":"63","author":"TJ Kamerzell","year":"2011","journal-title":"Adv Drug Deliver Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.addr.2011.06.011","article-title":"Interaction of formulation excipients with proteins in solution and in the dried state","volume":"63","author":"S Ohtake","year":"2011","journal-title":"Adv Drug Deliver Rev"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/jps.10184","article-title":"Effect of glycine on pH changes and protein stability during freeze-thawing in phosphate buffer systems","volume":"91","author":"KA Pikal-Cleland","year":"2002","journal-title":"J Pharm Sci"},{"key":"ref15","unstructured":"Rasband WS, ImageJ [internet]. Bethesda (MD): U.S. National Institutes of Health; 1997\u20132015. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/imagej.nih.gov\/ij\/\" xlink:type=\"simple\">http:\/\/imagej.nih.gov\/ij\/<\/ext-link>."},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/jps.20364","article-title":"Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and\/or immobilization in a glassy matrix?","volume":"94","author":"L Chang","year":"2005","journal-title":"J Pharm Sci"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s11095-007-9312-6","article-title":"Stabilizing effect of four types of disaccharide on the enzymatic activity of freeze-dried lactate dehydrogenase: step by step evaluation from freezing to storage","volume":"24","author":"K Kawai","year":"2007","journal-title":"Pharmaceut Res"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/abbi.1996.0305","article-title":"Physical factors affecting the storage stability of freeze-dried interleukin-1 receptor antagonist: glass transition and protein conformation","volume":"331","author":"BS Chang","year":"1996","journal-title":"Arch Biochem Biophys"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1023\/A:1012180707283","article-title":"Rational design of stable lyophilized protein formulations: some practical advice","volume":"14","author":"JF Carpenter","year":"1997","journal-title":"Pharmaceut Res"},{"issue":"35","key":"ref20","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1016\/j.vaccine.2007.06.054","article-title":"Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying","volume":"25","author":"JP Amorij","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/jps.20104","article-title":"Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation","volume":"93","author":"YF Maa","year":"2004","journal-title":"J Pharm Sci"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/B:PHAM.0000016234.73023.75","article-title":"Design of freeze-drying processes for pharmaceuticals: practical advice","volume":"21","author":"XC Tang","year":"2004","journal-title":"Pharmaceut Res"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/jps.10094","article-title":"Mannitol\u2013sucrose mixtures\u2014versatile formulations for protein lyophilization","volume":"91","author":"RE Johnson","year":"2002","journal-title":"J Pharm Sci"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/jps.20138","article-title":"The stability of lyophilized lipid\/DNA complexes during prolonged storage","volume":"93","author":"TK Armstrong","year":"2004","journal-title":"J Pharm Sci"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1021\/bi00435a044","article-title":"An infrared spectroscopic study of the interactions of carbohydrates with dried proteins","volume":"28","author":"JF Carpenter","year":"1989","journal-title":"Biochemistry-US"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0005-2736(00)00251-0","article-title":"Stabilization of lipid\/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis","volume":"1468","author":"SD Allison","year":"2000","journal-title":"BBA-Biomembranes"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/10837459809028500","article-title":"Characterization of the sucrose\/glycine\/water system by differential scanning calorimetry and freeze-drying microscopy","volume":"3","author":"K Kasraian","year":"1998","journal-title":"Pharm Dev Technol"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1023\/A:1016043114998","article-title":"Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist","volume":"13","author":"BS Chang","year":"1996","journal-title":"Pharm Res"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"E150","DOI":"10.1208\/pt060223","article-title":"Freeze-drying of proteins from a sucrose-glycine excipient system: effect of formulation composition on the initial recovery of protein activity","volume":"6","author":"W Liu","year":"2005","journal-title":"AAPS PharmSciTech"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0164692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:06:52Z","timestamp":1540217212000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0164692"}},"subtitle":[],"editor":[{"given":"Mohammed","family":"Alsharifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,16]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0164692","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,16]]}}}